YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug…
This article first appeared on GuruFocus. Total Revenue: 702 million SEK, up 4% year-on-year and 32% sequentially. Operating Result: 293 million SEK, corresponding to a 42% margin. Cash Position: 4.1 billion SEK at the end of the quarter.…
* Camurus AB (publ) H1 press release [https://www.camurus.com/media/press-releases/2026/camurus-interim-report-second-quarter-2026/] (CAMRF [https://seekingalpha.com/symbol/CAMRF]): EPS of SEK 4.05 (-2% Y/Y) * Total revenue: SEK 1,235M (fl…
LUND, Sweden, June 1, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that Eli Lilly and Company ("Lilly") has exercised its option to include amylin receptor agonists (amylin) in the collaboration and license agreement ent…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Camurus (OM:CAMX) drew fresh attention after recent share price moves, with the stock up slightly…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Automation Software Market size & share revenue was valued at approximately…
This article first appeared on GuruFocus. Release Date: May 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Camurus AB (CAMRF) reported a 15% sequential increase…
The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 (AstraZeneca), MAR002 (Marea Therapeutics), Paltusotine (Crinetic…
This article first appeared on GuruFocus. Release Date: February 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Camurus AB (CAMRF) achieved significant mileston…
As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this contex…
Amid continuing optimism about the European economy and company earnings, the pan-European STOXX Europe 600 Index recently ended 2.27% higher, reflecting a favorable interest rate environment. As major stock indexes across Europe rise, ide…
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the N…
As European markets navigate a mixed landscape, with the STOXX Europe 600 Index inching higher amid hopes for interest rate cuts in the U.S. and UK, investors are keenly observing opportunities that might arise from fluctuating economic in…
As global markets face a mix of challenges, including a record low in U.S. consumer sentiment and heightened scrutiny over AI spending, investors are increasingly focused on identifying undervalued stocks that may offer potential value opp…
CAM2056 showed weight and A1c reductions comparable to or exceeding those seen for weekly semaglutide (Wegovy®) Results include a 9.3% weight reduction with CAM2056 vs. 5.2% with weekly semaglutide at Day 85 Safety and tolerability were co…
This article first appeared on GuruFocus. Release Date: November 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Camurus AB (FRA:7CA) reported a strong profitabi…
* Camurus AB (publ) press release [https://www.camurus.com/media/press-releases/2025/camurus-interim-report-third-quarter-2025/] (OTCPK:CAMRF [https://seekingalpha.com/symbol/CAMRF]): Q3 EPS of SEK 3.19. * Profit before tax increased 48% t…
The gastrointestinal neuroendocrine tumors market is experiencing steady growth driven by increasing disease prevalence, improved diagnostic capabilities, and rising awareness of targeted therapies. Additionally, growing investment in rese…
The European stock market has recently faced challenges, with the pan-European STOXX Europe 600 Index declining amid concerns over U.S. Federal Reserve independence, tariff uncertainties, and political instability in key regions. Despite t…
As global markets navigate a period of mixed economic signals, with U.S. inflation holding steady and European indices facing pressure from geopolitical uncertainties, investors are keenly observing potential opportunities in undervalued s…
Amidst concerns over the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have experienced a downturn, with major indices like the STOXX Europe 600 Index closing lower. Despite these challenges, s…
As the European markets grapple with concerns over U.S. Federal Reserve independence, renewed tariff uncertainties, and political instability in France, major indices like the STOXX Europe 600 have seen declines. In this environment of cau…
As global markets navigate a landscape marked by steady inflation and geopolitical uncertainties, investors are closely watching indices that have seen mixed performances across regions. In such an environment, identifying undervalued stoc…
Amidst a challenging landscape marked by political instability and renewed tariff uncertainties, European markets have recently experienced a downturn, with the pan-European STOXX Europe 600 Index falling nearly 2% as concerns weigh on inv…
As European markets experience a boost from hopes of lower U.S. borrowing costs, with the pan-European STOXX Europe 600 Index rising by 1.40%, investors are keenly eyeing opportunities that might be trading at significant discounts. In suc…
LUND, Sweden, Aug. 28, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Oczyesa®, octreotide subcutaneous depot, marketing authorization for…
As European markets experience a boost from expectations of lower U.S. borrowing costs, with the pan-European STOXX Europe 600 Index rising by 1.40%, investors are keenly eyeing stocks that may be trading below their intrinsic value. In th…
As global markets navigate a complex landscape marked by potential interest rate cuts and fluctuating economic indicators, investors are keenly observing sectors that exhibit resilience amid these shifts. In this context, identifying under…
As European markets experience a modest upswing, buoyed by hopes of lower U.S. borrowing costs and an increase in business activity, investors are keenly observing potential opportunities in undervalued stocks. In this environment, identif…
In August 2025, European markets are experiencing a wave of optimism driven by easing trade tensions and potential U.S. interest rate cuts, with the STOXX Europe 600 Index rising by 1.18%. As investors navigate these favorable conditions,…
As global markets react to mixed inflation data and speculation around interest rate cuts, U.S. stocks have climbed to all-time highs, driven by favorable economic indicators and hopes of easing monetary policy. In this environment, identi…
As European markets experience a boost from easing trade tensions and optimism surrounding potential U.S. interest rate cuts, major indices like the STOXX Europe 600 have seen notable gains. In this environment of cautious optimism, identi…
As European markets navigate through a period of economic stagnation and mixed investor sentiment, the pan-European STOXX Europe 600 Index recently experienced a decline of 2.57%, reflecting broader concerns about trade deals and economic…
Amidst a backdrop of slowing job growth, renewed tariffs, and fluctuating economic indicators, global markets have experienced notable declines. As investors navigate these turbulent times, identifying stocks priced below their estimated i…
As European markets experience a downturn, with the STOXX Europe 600 Index falling by 2.57% amid dissatisfaction over trade negotiations with the U.S., investors are keenly searching for opportunities that might be undervalued amidst this…
Amid tentative optimism surrounding a potential EU-U.S. trade deal, the European market has shown resilience, with the pan-European STOXX Europe 600 Index rising modestly. As investors navigate this landscape of cautious optimism and geopo…